TherapeuticsMD signs merger agreement with Athene Parent for cash tender offer and merger

TherapeuticsMD, Inc.

Merger Agreement dated May 27, 2022 with Athene Parent, Inc. and Athene Merger Sub, Inc.
Cash tender offer to acquire all outstanding TXMD common shares, followed by a merger.
Board amended bylaws to exempt the transaction from Nevada's control share acquisition statute.
No deal price, premium, or expected closing date disclosed in this filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.